WTO TRIPS Council (February 2014) - India's intervention on IP and Innovation: University Technology PartnershipsSubmitted by thiru on 26. February 2014 - 8:24
On Tuesday, 25 February 2014, India delivered the following intervention at the WTO TRIPS Council on agenda item 12 (IP and Innovation: University Technology Partnerships). The United States of America tabled this standalone agenda item on University Technology Partnerships in the context of IP and Innovation.
Agenda 12 : IP and Innovation: University Technology Partnerships
TRIPS Council (February 2014) US tables agenda item on IP & Innovation: University Technology PartnershipsSubmitted by thiru on 19. February 2014 - 2:46
The following WTO airgram WTO/AIR/4240/REV.1 (14 February 2014) contains the agenda for the upcoming WTO Council for TRIPS meeting to be held in Geneva from Tuesday, 25 February 2014 to Wednesday, 26 February 2014.
Public Comments by Brian Pomper-Executive Director of the Innovation Alliance and Alliance for Fair Trade with IndiaSubmitted by thiru on 12. February 2014 - 9:34
Brian Arthur Pomper is a partner at the law firm of Akin Gump.
Mr. Pomper formerly served as chief international trade counsel to Senate Finance Committee Chairman Max Baucus (D-MT). In that role, he was responsible for advising Chairman Baucus and other members of the Senate Finance Committee on all aspects of the Committee’s international trade and economic agenda.
Special 301: NFTC puts plain packaging policies of Australia, EU, Thailand, UK, Ireland and New Zealand under the spotlightSubmitted by thiru on 11. February 2014 - 4:21
The National Foreign Trade Council (NFTC) submission (7 February 2014, Docket USTR-2013-0040) to USTR's 2014 Special 301 Review contains a section on plain packaging policies in the context of the protection of trademarks.
Composition of the WIPO Coordination Committee: 83 countries invested with power to nominate the WIPO Director GeneralSubmitted by thiru on 3. February 2014 - 15:15
According to a press release issued by the World Intellectual Property Organization (WIPO) on 6 December 2013, four candidatures for the post of Director General were received before the deadline for nominations (5 PM, 6 December 2013) expired.
The WIPO press release noted that,
The candidates are (in alphabetical order of names of candidates): Mr. Francis Gurry (Australia), Mr. Geoffrey Onyeama (Nigeria), Mr. Jüri Seilenthal (Estonia), and Mr. Alfredo Suescum (Panama).
WIPO norm-setting on IP and genetic resources: will impasse on mandatory disclosure and the nature of instrument be resolved?Submitted by thiru on 3. February 2014 - 9:31
It is crunch time for WIPO's Intergovernmental Committee on Genetic Resources, Traditional Knowledge and Folklore (IGC). The 26th session meets from 3-7 February 2014 in Geneva. This week's session will focus on setting international norms for the protection of genetic resources against misappropriation and resolving two key areas of divergence: 1) the nature of the instrument and 2) the disclosure of origin requirement.
UPDATED- SCP20: Current state of play as countries clash on patents and health (WIPO Standing Committee on the Law of Patents)Submitted by thiru on 31. January 2014 - 8:39
On Friday, 31 January 2014 (6:30 PM Geneva time) the WIPO Standing Committee on the Law of Patents (SCP) resumed in plenary mode to discuss the facilitator's text (Mr. Victor Portelli, Australia) on the future work of this committee including activities on 1) Exceptions and Limitations to Patent Rights, 2) Quality of Patents, including Opposition Systems, 3) Patents and Health, 4 Confidentiality of communications between clients and their patent advisors and 5) Transfer of Technology.
20TH Session of the Standing Committee on the Law of Patents
Statement by Kenya
Agenda Item No. 8: Patents and Health, 28th January 2014
Thank you Mr. Chairman for giving Kenya the floor.
Kenya supports the statement made by Algeria on behalf of the African Group and the proposal put forward by the Group and the DAG.
KEI Intervention at SCP20 on Patents and Health
28 January 2014
Thank you Chair.
Intervention of India at EB134 expressing solidarity with the Republic of South Africa in light of PharmagateSubmitted by thiru on 27. January 2014 - 8:35
During heated discussions on the topic of access to essential medicines at the 134th session of the World Health Organization's Executive Board, India delivered the following statement on Thursday, 23 January 2014 expressing solidarity with the Republic of South Africa in light of the Pharmagate exposé.
SCP20: Opening statement of the European Union at WIPO's Standing Committee on the Law of Patents, 27 January 2014Submitted by thiru on 27. January 2014 - 8:25
On 27 January 2014, Greece, on behalf of the European Union, delivered this opening statement at the 20th session of WIPO Standing Committee on the Law of Patents (SCP). The EU's priorities for WIPO's patent committee include quality of patents (including opposition systems), work sharing and confidentiality of communication between client and their patent advisors.
With respect to limitations and exceptions to patent rights, the EU said,
Intervention of the South Centre at EB134 expressing solidarity with the Republic of South Africa (English translation)Submitted by thiru on 24. January 2014 - 10:42
This is the English translation of the intervention delivered by the South Centre on Thursday, 23 January 2014 at the 134th session of the World Health Organization's Executive Board expressing solidarity with the Government of the Republic of South Africa following the Pharmagate exposé.
Thank you, Madam President, for giving us the floor.
The following are some quotes by countries, companies, academics and other actors stating, suggesting or implying claiming that drugs not on the WHO Model List of Essential Medicines (WHO EML) should not be subject to a compulsory license.
Bayer. Political Principles.
Innovation requires investment.
Good ideas must be worthwhile.
On Thursday, 23 January 2014, Malebona Precious Matsoso (Director General of the South African National Department of Health) delivered the the following intervention at the 134th session of the World Health Organization's Executive Board under agenda item 9.7 on Access to essential medicines in response to the recent Pharmagate imbroglio.